Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing risperidone to placebo for behavioral disturbances in dementia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Vascular Dementia

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Janssen, LP | Conditions: Dementia, Alzheimer Disease | Phase 3 | Status: COMPLETED